The Maharashtra Food and Drug Administration (FDA) has cracked down on McDonald’s for allegedly using cheese substitutes instead of real cheese in their products, according to a report by TOI. The FDA’s action comes after an inspection of a McDonald’s outlet in Ahmednagar, where officials found the use of cheese analogues, which are substitutes designed to mimic the taste and texture of traditional dairy cheese.
The FDA alleges that McDonald’s failed to disclose the use of cheese analogues on food labels or electronic display boards, misleading consumers into believing they were consuming real cheese. The FDA initiated action against McDonald’s in October, issuing a show-cause notice to the establishment and suspending its license due to unsatisfactory explanations.
FDA commissioner Abhimanyu Kale emphasized the misleading nature of not disclosing the use of cheese analogues, stating that it could have health implications for consumers. He also indicated plans to investigate other fast-food pizza and burger joints for similar practices.
In response to the FDA’s actions, McDonald’s renamed products by removing the word “cheese” from their names. However, the company denied using substitutes and provided letters from cheese suppliers as evidence of using real cheese in their products.
The FDA’s crackdown highlights the importance of clear labeling and transparency in food products, particularly concerning allergens and dietary concerns. The incident serves as a reminder for consumers to be aware of the ingredients in the foods they consume and for food establishments to adhere to labeling regulations.
